SC
SCPH

Steven Cohen’s scPharmaceuticals SCPH Stock Holding History

Steven Cohen’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-500
Closed -$4.54K – 2716
2023
Q1 		$4.54K Buy
+500
New +$3.66K ﹤0.01% 2088

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steven Cohen's SCPH Position: Q2 2023 in Review

Steven Cohen sold out of scPharmaceuticals (SCPH) in Q2 2023, closing a stake of 500 shares — an estimated $4.54K sold.

Steven Cohen first reported a position in SCPH in Q1 2023 and held it in 1 quarter. The position peaked at $4.54K in Q1 2023. 81 funds tracked by Wall St. Rank hold SCPH as of Q2 2023.

  • Steven Cohen reported no remaining scPharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Steven Cohen sold 500 scPharmaceuticals shares in Q2 2023, an estimated $4.54K.
  • Steven Cohen first reported a position in scPharmaceuticals in Q1 2023 and held it in 1 quarter.
  • Steven Cohen's scPharmaceuticals position peaked at $4.54K in Q1 2023.
  • 81 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2023.

Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.